Ajanta Pharma
Ajanta Pharma Limited is an India-based specialty pharmaceutical manufacturer with branded-generic businesses in multiple regions and a separate generics business in the United States. Consumers may encounter the Ajanta name while researching a generic medicine, a market-specific brand, or sexual-health product names such as Kamagra.
The company name alone is not enough to determine what a product contains or where it is approved. Ajanta sells different portfolios in different markets, and the same active ingredient may appear under a branded name in one country and as a U.S. generic in another. This parent page explains that structure and directs detailed sildenafil and tadalafil questions to the site’s dedicated child pages.
About Ajanta Pharma
Ajanta Pharma’s current corporate materials describe a specialty pharmaceutical company operating across more than 30 countries. Its business includes branded generics in India and emerging markets and a U.S. generics operation through Ajanta Pharma USA.
The company’s current India portfolio emphasizes cardiology, dermatology, ophthalmology, pain management, nephrology, and gynaecology. In other emerging markets, Ajanta reports activity across areas including cardiology, diabetes, ophthalmology, anti-infectives, malaria, pain, respiratory care, paediatrics, gynaecology, and general health.
Ajanta also operates multiple manufacturing facilities in India covering tablets, capsules, oral suspensions, liquids, sterile eye drops, topical products, injectables, jelly formulations, and active pharmaceutical ingredients. That manufacturing breadth helps explain why the same company name appears across very different product categories.
Ajanta Pharma Products and Generic Medicines
A manufacturer, a brand, and an active ingredient are three different identifiers. Ajanta Pharma is the manufacturer or corporate group. Kamagra is an example of a product brand associated with Ajanta in specific markets. Sildenafil is the active ingredient in certain products. A user comparing medicines should keep those levels separate.
The distinction becomes particularly important with generic drugs. In the United States, Ajanta Pharma USA markets FDA-approved generic products under standard nonproprietary names. In other countries, Ajanta may use branded product names. The package name a consumer sees therefore depends partly on market and distribution channel.
Current Ajanta corporate materials state that its U.S. business has dozens of approved ANDAs and that its products are marketed through Ajanta Pharma USA. The current U.S. product catalog includes multiple strengths and dosage forms across many therapeutic areas.
Ajanta Sildenafil and Kamagra Products
Kamagra is a useful example of why product research needs market context. The official Ajanta Pharma Philippines site currently lists Kamagra with sildenafil citrate as its generic ingredient. Government drug registers in some other countries have also recorded Kamagra products manufactured by Ajanta Pharma.
That verifies the relationship between Ajanta, the Kamagra name, and sildenafil in those specific market records. It does not establish that Kamagra is an FDA-approved U.S. brand or that it is currently marketed in every country where sildenafil itself is approved.
Ajanta’s U.S. portfolio uses a different product framework. Current Ajanta Pharma USA pages list Sildenafil Tablets, USP in 25 mg, 50 mg, and 100 mg strengths as prescription generics referencing Viagra for erectile dysfunction, with product-specific U.S. labeling and therapeutic-equivalence information. Those U.S. generic products should be evaluated by their own NDC, label, and approval details rather than by assuming equivalence with a market-specific Kamagra package.
For deeper coverage of the brand and ingredient relationship, see Ajanta Pharma and Kamagra products. The child page is the place for product-level details; this parent page keeps the focus on manufacturer and market context.
Ajanta Tadalafil Products
Ajanta Pharma also has tadalafil products, but the product name and indication vary by market. Current Ajanta Pharma USA product pages list Tadalafil Tablets, USP in several strengths within the Cialis-reference generic category for erectile dysfunction and benign prostatic hyperplasia. Ajanta Pharma USA also lists a separate tadalafil 20 mg product referencing Adcirca for pulmonary arterial hypertension.
That difference is important. Two medicines can contain tadalafil while carrying different indications and product labeling. Consumers should identify which product they are researching rather than treating every tadalafil package as interchangeable.
The site’s detailed manufacturer-plus-ingredient reference is available under Ajanta tadalafil products.
Product Forms, Strengths and Market Differences
Ajanta’s manufacturing operations support a wide range of dosage forms, and the company’s branded-generic business is organized by market. That means packaging, strength, dosage form, brand name, and availability can differ among countries even when the manufacturer is the same.
For example, Ajanta Pharma USA currently lists sildenafil tablets for erectile dysfunction in 25 mg, 50 mg, and 100 mg strengths. Its U.S. tadalafil listings include 2.5 mg, 5 mg, 10 mg, and 20 mg products in the Cialis-reference category, while a separate tadalafil 20 mg product is listed for pulmonary arterial hypertension. These are current product-specific examples from the U.S. subsidiary, not a template for Ajanta products worldwide.
Kamagra illustrates the other side of the same issue: the name is used in at least some non-U.S. markets for an Ajanta sildenafil product. A consumer seeing “Kamagra,” “sildenafil,” or “Ajanta sildenafil” therefore needs to check the exact market and package rather than assume that all three phrases refer to the same registered product.
Regulatory Status and Availability
Regulatory status belongs to a particular product in a particular jurisdiction. Approval of sildenafil or tadalafil as active ingredients does not automatically approve every branded product that contains them. Likewise, an Ajanta product registered in one country should not be described as “available in the U.S.” unless the exact U.S. product can be verified.
For U.S. products, FDA resources such as the Orange Book and current labeling databases allow searches by active ingredient, applicant, application number, dosage form, and product name. Ajanta Pharma USA also publishes product pages with NDCs, reference-listed-drug information, strengths, and therapeutic-equivalence codes for its U.S. portfolio.
Availability adds another layer. A product can be approved yet not be stocked by a particular pharmacy at a particular time. Conversely, an overseas brand seen online may not correspond to a product that is lawfully marketed in the user’s jurisdiction. This page therefore does not make a blanket “available” or “legal” claim for Kamagra, Tadalis, Apcalis, or any other market-specific product name.
Comparing Ajanta Product Information
A useful comparison starts with objective identifiers rather than brand reputation. Compare:
- active ingredient — for example, sildenafil versus tadalafil;
- strength — the amount of active ingredient in the labeled dosage unit;
- dosage form — tablet, capsule, liquid, jelly, or another form;
- manufacturer or labeler — the company responsible for the specific product;
- regulatory status — the approval or registration of that exact product in the relevant market;
- product name — which may be a brand in one market or a generic label in another.
Those factors are more informative than assuming one medicine is better simply because of the manufacturer name. For prescription products, the approved labeling and the individual prescription remain more important than online brand comparisons.
Research Sources and Manufacturer Information
The Ajanta manufacturer reference section uses medication information sources to help explain manufacturer identity, product relationships and market-specific records. Information pages may rely on a combination of official manufacturer information, regulatory databases, national medicines regulators, authoritative medication databases and historical regulatory records where relevant.
The available source information can differ depending on the product, country, regulatory market and historical period being researched. Product information from one market should be interpreted in the context of that specific market rather than assumed to represent all regions.
About Ajanta Product Information
Ajanta Pharma Limited product information can vary between countries and markets. The Medication Information reference section may discuss manufacturer identity, product names, active ingredients, dosage forms and regulatory context.
These references are intended to provide product and manufacturer context. They do not indicate a partnership between Paulsen’s Pharmacy and Ajanta Pharma, product supply arrangements, current availability or current stock status.
For a broader explanation of how medication information is researched and interpreted, see Medication Information Research Methodology. The main reference library is available through Medication Information.
Questions About an Ajanta Pharma Product
If you are researching an Ajanta product before filling a prescription or asking about access, note the exact product name, active ingredient, strength, dosage form, country or market, and any manufacturer or labeler information shown on the package. If the product is from the United States, an NDC can also help identify the exact listing.
For a broader explanation of how manufacturer names, brands, active ingredients, and market status fit together, return to Medication Information. That approach is more reliable than carrying an old product description or overseas brand claim into a different market without checking the current record.
Reviewed by: Dr. Nancy Ann Curosh